Latest News
8 Things to Know About Johnson & Johnson's Janssen COVID-19 Vaccine
As the company announces that its single-dose Janssen COVID-19 Vaccine has been granted Emergency Use Authorization by the U.S. Food and Drug Administration, here are some key facts about how it works (hint: it involves an inactivated common cold virus), how it has been studied, how it would be transported—and more.
Today's Top Reads
Close
-
Did you like reading this story? Click the heart to show your love.
86 -
Did you like reading this story? Click the heart to show your love.
51 -
Did you like reading this story? Click the heart to show your love.
89
Did you like reading this story? Click the heart to show your love.
1222
Learn about the innovative ways the company is mobilizing to help combat the global outbreak caused by the novel coronavirus.
More from Johnson & Johnson
-
September 19, 2022Take a look inside the new cutting-edge hub for medical innovation where company scientists and other researchers will collaborate to help find solutions for some of the world’s toughest health challenges.
-
July 19, 2022Check out this infographic breakdown of the company’s second-quarter 2022 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
-
June 08, 2022Championing global health equity, advancing environmental health and empowering its employees to be their best are just some of the ways Johnson & Johnson is working to help improve the well-being of people around the world. The company's 2021 Health for Humanity Report reveals just how far it's come toward these ambitious goals.
